TacticScaleWhat Bloomage BioTechnology (华熙生物) Does & How It Makes Money (688363.SS)
Updated October 2026 · reflects Bloomage BioTechnology's latest reported financials
Chinese maker of hyaluronic acid and other bioactive ingredients. It makes money by producing and selling branded bioactive ingredients, mainly hyaluronic acid in many grades and forms, plus ergothioneine, ectoine, collagen peptides and polyglutamate.
How Bloomage BioTechnology makes money
It makes money by producing and selling branded bioactive ingredients, mainly hyaluronic acid in many grades and forms, plus ergothioneine, ectoine, collagen peptides and polyglutamate. These are sold for use in beauty and care, pharma and aesthetics, and nutrition and health products.
What Bloomage BioTechnology does
Bloomage BioTechnology is a Jinan-based company founded in 2000 that develops, produces and sells bioactive materials. Hyaluronic acid is at the center of the business. It sells it in many forms: high and low molecular weight, oligo, hydrolyzed, acetylated, zinc-bound, cross-linked elastomer and oil-dispersed grades under the Hybloom and Hymagic brands, along with specialty grades such as UltraHA for gut health. The company also sells a wider range of actives made by fermentation and biotech processes. These include ergothioneine (Bioyouth-EGT, MitoEGT), ectoine (Bioecto, Bloomecto), polyglutamate, GABA, PQQ, N-acetylneuraminic acid, ferment filtrates and collagen peptides. Its products serve three markets: beauty and personal care, pharma and aesthetics, and nutrition and health.
Products & services
- Hybloom sodium hyaluronate series
- Hymagic hyaluronic acid derivatives (4D, AcHA, VCHA)
- Bioyouth-EGT ergothioneine
- Bioecto ectoine
- Hyatrue / UltraHA food- and pharma-grade hyaluronic acid
- Biovivid collagen peptide
华熙生物是做什么的？
华熙生物成立于2000年，总部位于山东济南，主要研发、生产和销售生物活性材料。透明质酸（玻尿酸）是公司的核心产品，分为高分子、低分子、寡聚、水解、乙酰化、锌盐、交联弹性体、油分散等多种规格，主要品牌有Hybloom和Hymagic，还有用于肠道健康等特定用途的UltraHA系列。 公司还生产麦角硫因、依克多因、聚谷氨酸、γ-氨基丁酸、PQQ、唾液酸、发酵滤液、胶原蛋白肽等多种生物活性成分。这些产品用于美妆个护、医药与医美、营养健康三大领域。
What is Bloomage BioTechnology worth?
On an owner-earnings DCF, Bloomage BioTechnology's most-likely value is about ¥13 versus a recent price near ¥35 (159% above fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~¥8) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Hybio Pharmaceutical (300199.SZ) · Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (600866.SS) · BrightGene Bio-Medical Technology (688166.SS) · Cathay Biotech (688065.SS)